The relationship between ANGPTL8 and NAFLD remains unclear, with controversial reports indicating increased [23,30,31] or decreased [32] circulating levels of ANGPTL8 in patients with biopsy-proven NAFLD compared with healthy volunteers. This evidence concerns the gene ANGPTL8 and metabolic dysfunction-associated steatotic liver disease.